Enregistré dans:
| Auteurs principaux: | Rohita Reji, Kerri Novak |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2026
|
| Sujets: | |
| Accès en ligne: | https://onlinelibrary.wiley.com/doi/10.1111/apt.70513 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study
par: Clara Yzet, et autres
Publié: (2025)
par: Clara Yzet, et autres
Publié: (2025)
Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease
par: Moeko Komatsu, et autres
Publié: (2024)
par: Moeko Komatsu, et autres
Publié: (2024)
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
par: Shlomi Cohen, et autres
Publié: (2025)
par: Shlomi Cohen, et autres
Publié: (2025)
Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
par: Mohammad Shehab, et autres
Publié: (2025)
par: Mohammad Shehab, et autres
Publié: (2025)
Editorial: Upadacitinib in Perianal Crohn's Disease
par: Manjeet Kumar Goyal, et autres
Publié: (2026)
par: Manjeet Kumar Goyal, et autres
Publié: (2026)
Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
par: Runqi Wang, et autres
Publié: (2026)
par: Runqi Wang, et autres
Publié: (2026)
Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
par: Vincenzo Stranges, et autres
Publié: (2025)
par: Vincenzo Stranges, et autres
Publié: (2025)
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
par: Jeffrey D McCurdy, et autres
Publié: (2025)
par: Jeffrey D McCurdy, et autres
Publié: (2025)
Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
par: Runqi Wang, et autres
Publié: (2026)
par: Runqi Wang, et autres
Publié: (2026)
Editorial: Examining Perianal Fistulising Crohn's Disease Through the Lens of Wound Repair
par: Tim Eglinton
Publié: (2025)
par: Tim Eglinton
Publié: (2025)
Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease?
par: C. Ramos‐Belinchon, et autres
Publié: (2025)
par: C. Ramos‐Belinchon, et autres
Publié: (2025)
Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
par: José Luis Rueda García, et autres
Publié: (2026)
par: José Luis Rueda García, et autres
Publié: (2026)
Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
par: Jeffrey D McCurdy, et autres
Publié: (2024)
par: Jeffrey D McCurdy, et autres
Publié: (2024)
Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease
par: Marco Mendolaro, et autres
Publié: (2025)
par: Marco Mendolaro, et autres
Publié: (2025)
Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
par: Lingna Ye, et autres
Publié: (2025)
par: Lingna Ye, et autres
Publié: (2025)
Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
par: Nicolas Richard, et autres
Publié: (2025)
par: Nicolas Richard, et autres
Publié: (2025)
Letter: Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next‐Generation Sequencing
par: Maryam Irshad, et autres
Publié: (2025)
par: Maryam Irshad, et autres
Publié: (2025)
Letter: Bowel Preparation Quality in Patients With Crohn's Disease
par: Tamar Schildkraut, et autres
Publié: (2024)
par: Tamar Schildkraut, et autres
Publié: (2024)
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
par: Cathy Lu, et autres
Publié: (2024)
par: Cathy Lu, et autres
Publié: (2024)
Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
par: Alyssa M. Parian, et autres
Publié: (2025)
par: Alyssa M. Parian, et autres
Publié: (2025)
Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns
par: Kuan‐Ju Lin, et autres
Publié: (2025)
par: Kuan‐Ju Lin, et autres
Publié: (2025)
Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Antoine Meyer, et autres
Publié: (2025)
par: Antoine Meyer, et autres
Publié: (2025)
Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU
par: María José Casanova, et autres
Publié: (2025)
par: María José Casanova, et autres
Publié: (2025)
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study
par: Péter Bacsur, et autres
Publié: (2024)
par: Péter Bacsur, et autres
Publié: (2024)
Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
par: Zhidong Zhou, et autres
Publié: (2025)
par: Zhidong Zhou, et autres
Publié: (2025)
Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
par: Virginia Solitano, et autres
Publié: (2024)
par: Virginia Solitano, et autres
Publié: (2024)
Editorial: Remission Ambition—How Far Should We Push in Older Adults? Authors' Reply
par: Catherine Z. Tang, et autres
Publié: (2025)
par: Catherine Z. Tang, et autres
Publié: (2025)
Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
par: Lichao Qiao, et autres
Publié: (2025)
par: Lichao Qiao, et autres
Publié: (2025)
Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras
par: Daniel Tassone, et autres
Publié: (2024)
par: Daniel Tassone, et autres
Publié: (2024)
Letter: The Simple Endoscopic Score for Predicting Crohn's Disease Progression—Not as Simple as It Sounds
par: Ziheng Calvin Xu, et autres
Publié: (2025)
par: Ziheng Calvin Xu, et autres
Publié: (2025)
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise
par: Weilun Gao, et autres
Publié: (2024)
par: Weilun Gao, et autres
Publié: (2024)
Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply
par: Lucie Simonis, et autres
Publié: (2025)
par: Lucie Simonis, et autres
Publié: (2025)
Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?
par: Neil Chanchlani, et autres
Publié: (2024)
par: Neil Chanchlani, et autres
Publié: (2024)
Editorial: Foretelling the future—Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease
par: Siri A. Urquhart, et autres
Publié: (2024)
par: Siri A. Urquhart, et autres
Publié: (2024)
Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice
par: Basile Njei, et autres
Publié: (2024)
par: Basile Njei, et autres
Publié: (2024)
Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
par: Nicholas Clark, et autres
Publié: (2025)
par: Nicholas Clark, et autres
Publié: (2025)
Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Publié: (2024)
Publié: (2024)
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply
par: Péter Bacsur, et autres
Publié: (2024)
par: Péter Bacsur, et autres
Publié: (2024)
One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
par: Nicolas Richard, et autres
Publié: (2026)
par: Nicolas Richard, et autres
Publié: (2026)
Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
par: Tarun Chhibba
Publié: (2024)
par: Tarun Chhibba
Publié: (2024)
Documents similaires
-
Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study
par: Clara Yzet, et autres
Publié: (2025) -
Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease
par: Moeko Komatsu, et autres
Publié: (2024) -
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
par: Shlomi Cohen, et autres
Publié: (2025) -
Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
par: Mohammad Shehab, et autres
Publié: (2025) -
Editorial: Upadacitinib in Perianal Crohn's Disease
par: Manjeet Kumar Goyal, et autres
Publié: (2026)